PALVELLA THERAPEUTICS, INC. (PVLA)

Data as of Sep 18, 2026, from SEC Form 4 filings.

Net insider selling (90d)Watch PVLA

See up to 3 months of PVLA. The 7-day demo opens the 1M and 3M ranges and puts PVLA on your watchlist.

Latest PVLA insider trades

Kathleen Goin - Officer
Open-market sale$251K
Sep 16, 2026
Kathleen Goin - Officer
Open-market sale$151K

About PALVELLA THERAPEUTICS, INC. (PVLA)

The SEC lists PALVELLA THERAPEUTICS, INC. under CIK 0001583648, in pharmaceutical preparations. It is grouped with Health Care companies on this site.

Sector: Health Care

SEC filings for PVLA on EDGAR

PVLA Form 4 activity by transaction type, last 90 days

Form 4 transaction type	Transactions	Shares	Total value
Open-market sale	22	40,719	$6.17M
Option exercise	14	26,438

Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.

PVLA insider transactions (Form 4)

103

48 Form 4 filings on record, the earliest from Oct 28, 2024, newest first. Filing history page 1 of 2.

Date	Insider	Transaction	Security	Shares	Price	Value
Sep 16, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Sep 16, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Sep 16, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,659	$151.16^{footnote F2}	$251K
Sep 16, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	989	$152.36^{footnote F3}	$151K
Sep 16, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,654	$153.24^{footnote F4}	$253K
Sep 16, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Sep 16, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.755 to $151.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.77 to $152.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.78 to $153.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Sep 11, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	6,520	$150.62^{footnote F3}	$982K
Sep 11, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	4,577	$151.72^{footnote F4}	$694K
Sep 11, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	1,274	$153.06^{footnote F5}	$195K
Sep 14, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	5,632	$151.46^{footnote F6}	$853K
Sep 14, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	6,160	$152.12^{footnote F7}	$937K
Sep 14, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	1,560	$153.10^{footnote F8}	$239K
Sep 15, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	954	$149.38^{footnote F9}	$143K
Sep 15, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	263	$150.40^{footnote F10}	$40K
Sep 15, 2026	George M. Jenkins - Director	Open-market sale	Common Stock	560	$151.33^{footnote F11}	$85K
Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.23 to $151.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.23 to $152.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.42 to $153.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F6 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.80 to $151.785, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F7 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.80 to $152.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F8 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.88 to $153.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F9 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.90 to $149.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F10 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.0525 to $151.0225, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F11 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.16 to $151.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Sep 2, 2026	Christopher P. Kiritsy - Director	Option exercise	Common Stock	313^{footnote F1}	$127.20^{footnote F1}	$40K
Sep 2, 2026	Christopher P. Kiritsy - Director	Open-market sale	Common Stock	313	$157.00	$49K
Sep 2, 2026	Christopher P. Kiritsy - Director	Option exercise	Stock Option (Right to Buy)	313^{footnote F1}	$0.00	-
Footnote F1 (price, shares): The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-80 reverse stock split, which became effective on April 23, 2024.
Aug 19, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Aug 19, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Aug 19, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,500	$151.39^{footnote F2}	$227K
Aug 19, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,998	$151.80^{footnote F3}	$303K
Aug 19, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	400	$153.00^{footnote F4}	$61K
Aug 19, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	102	$155.59^{footnote F5}	$16K
Aug 19, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	302	$156.77	$47K
Aug 19, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Aug 19, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.62 to $151.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.665 to $152.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.93 to $153.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.58 to $155.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Jul 15, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Jul 15, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Jul 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	522	$147.14^{footnote F2}	$77K
Jul 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	840	$148.40^{footnote F3}	$125K
Jul 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,029	$149.27^{footnote F4}	$154K
Jul 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,911	$150.25^{footnote F5}	$287K
Jul 15, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Jul 15, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.77 to $147.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.79 to $148.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.79 to $149.765, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.79 to $150.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Jun 29, 2026	Matthew Pauls - Director	Grant or award	Stock Option (Right to Buy)	6,000	$0.00	-
Jun 17, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Jun 17, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Jun 17, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	2,390	$110.26^{footnote F2}	$264K
Jun 17, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,887	$111.31^{footnote F3}	$210K
Jun 17, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	25	$112.23	$3K
Jun 17, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Jun 17, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.055 to $110.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.08 to $111.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Jun 12, 2026	Matthew E. Korenberg - Officer	Option exercise	Common Stock	1,000	$13.60	$14K
Jun 12, 2026	Matthew E. Korenberg - Officer	Option exercise	Stock Option (Right to Buy)	1,000	$0.00	-
Jun 10, 2026	Christopher P. Kiritsy - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
Jun 10, 2026	George M. Jenkins - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
Jun 10, 2026	Elaine J. Heron - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
Jun 10, 2026	John Doux - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
Jun 10, 2026	Todd C. Davis - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
Jun 10, 2026	Tadd S. Wessel - Director	Grant or award	Stock Option (Right to Buy)	3,000	$0.00	-
May 20, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
May 20, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
May 20, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	3,363	$110.35^{footnote F2}	$371K
May 20, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	891	$111.30^{footnote F3}	$99K
May 20, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	48	$111.90	$5K
May 20, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
May 20, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.87 to $110.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.89 to $111.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Apr 15, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Apr 15, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Apr 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,502	$125.96^{footnote F2}	$189K
Apr 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,500	$127.13^{footnote F3}	$191K
Apr 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	561	$128.23^{footnote F4}	$72K
Apr 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	639	$129.17^{footnote F5}	$83K
Apr 15, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	100	$130.33	$13K
Apr 15, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Apr 15, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.53 to $126.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.77 to $127.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.88 to $128.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F5 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.95 to $129.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Apr 13, 2026	John Doux - Director	Grant or award	Stock Option (Right to Buy)	6,000	$0.00	-
Mar 30, 2026	George M. Jenkins - Director	Open-market purchase	Common Stock	445	$112.30	$50K
Mar 18, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Mar 18, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Mar 18, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	2,268	$117.56^{footnote F2}	$267K
Mar 18, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,730	$118.37^{footnote F3}	$205K
Mar 18, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	304	$119.08^{footnote F4}	$36K
Mar 18, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Mar 18, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.995 to $117.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F4 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.08 to $119.3767, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Feb 27, 2026	George M. Jenkins - Director	Open-market purchase	Common Stock	4,000^{footnote F1}	$125.00	$500K
Footnote F1 (shares): Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.
Feb 27, 2026	Elaine J. Heron - Director	Open-market purchase	Common Stock	2,400^{footnote F1}	$125.00	$300K
Footnote F1 (shares): Represents shares of common stock purchased in the underwritten offering of Palvella Therapeutics, Inc. at the offering price, which closed on February 27, 2026.
Feb 18, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Feb 18, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	3,026	$79.16^{footnote F2}	$240K
Feb 18, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Feb 18, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	1,276	$79.97^{footnote F3}	$102K
Feb 18, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Feb 18, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.75 to $79.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.775 to $80.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the… Full note on SEC EDGAR
Feb 5, 2026	Jeffrey S. Martini - Officer	Grant or award	Stock Option (Right to Buy)	64,318	$0.00	-
Feb 5, 2026	Ashley Hartmann Kline - Officer	Grant or award	Stock Option (Right to Buy)	38,517	$0.00	-
Feb 5, 2026	Wes Kaupinen - Officer	Grant or award	Stock Option (Right to Buy)	124,603	$0.00	-
Feb 5, 2026	Matthew E. Korenberg - Officer	Grant or award	Stock Option (Right to Buy)	44,123	$0.00	-
Feb 5, 2026	Kathleen Goin - Officer	Grant or award	Stock Option (Right to Buy)	48,956	$0.00	-
Jan 21, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Jan 21, 2026	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Jan 21, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	553	$95.49	$53K
Jan 21, 2026	Kathleen Goin - Officer	Open-market sale	Common Stock	3,749	$97.94	$367K
Jan 21, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Jan 21, 2026	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Nov 19, 2025	Kathleen Goin - Officer	Option exercise	Common Stock	2,148	$9.08	$20K
Nov 19, 2025	Kathleen Goin - Officer	Open-market sale	Common Stock	1,500	$85.72^{footnote F2}	$129K
Nov 19, 2025	Kathleen Goin - Officer	Open-market sale	Common Stock	2,802	$86.51^{footnote F3}	$242K
Nov 19, 2025	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,154	$0.00	-
Nov 19, 2025	Kathleen Goin - Officer	Option exercise	Stock Option (Right to Buy)	2,148	$0.00	-
Nov 19, 2025	Kathleen Goin - Officer	Option exercise	Common Stock	2,154	$7.14	$15K
Footnote F2 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.475 to $86.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR Footnote F3 (price): The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.485 to $86.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and… Full note on SEC EDGAR
Jun 10, 2025	George M. Jenkins - Director	Grant or award	Non-Qualified Stock Option (right to buy)	12,350	$0.00	-

Recent PVLA Form 8-K filings

Read PVLA company news

Aug 4, 2026Item 2.02, 7.01, 9.01

Read the filing on SEC EDGAR

Jul 14, 2026Item 8.01, 9.01

Read the filing on SEC EDGAR

Jun 30, 2026Item 5.02

Read the filing on SEC EDGAR

Jun 16, 2026Item 5.02, 5.07, 9.01

Recent PVLA Form 144 notices of proposed sale

An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.

Filed	Filer	Relationship	Shares	Market value	Notice
Oct 13, 2026	JENKINS GEORGE M	Director	27,500	$3.70M	View on EDGAR
Sep 16, 2026	Goin Kathleen	Officer	4,302

PVLA insider trading FAQ

What is the latest insider trade for PVLA?

PALVELLA THERAPEUTICS, INC. (PVLA) had 5 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for PVLA runs to 48 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.

How many insiders are buying PVLA stock?

No insider purchases of PVLA were filed in the last 90 days. 7 purchases are on record for this company.

How many insiders are selling PVLA stock?

22 insider sales of PVLA were filed in the last 90 days, totaling $6.17M.

Where can I see PVLA SEC filings (Form 4, 10-K, 10-Q, 8-K)?

This page collects PVLA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.

More Health Care companies with insider activity

Recent insider filings

The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.

Sep 18, 2026 - Kathleen Goin view on EDGAR
Sep 16, 2026 - George M. Jenkins view on EDGAR
Sep 4, 2026 - Christopher P. Kiritsy view on EDGAR
Aug 20, 2026 - Kathleen Goin view on EDGAR
Jul 17, 2026 - Kathleen Goin view on EDGAR
Jul 1, 2026 - Matthew Pauls view on EDGAR
Jun 22, 2026 - Kathleen Goin view on EDGAR
Jun 16, 2026 - Matthew E. Korenberg view on EDGAR
Jun 12, 2026 - Christopher P. Kiritsy view on EDGAR

Related companies with recent insider activity

Learn more

Insider selling: signal or noise?: Why most insider sales are routine, and the few patterns worth a second look.
Form 144 vs Form 4: A Form 144 announces a planned sale; the Form 4 reports it after it happens.
Insider activity in Health Care: Where PVLA's peers are being bought and sold.
Every recent Form 4: The market-wide feed, updated as filings arrive from SEC EDGAR.

Follow PVLA with a 7-day demo

PVLA on your watchlist
Every PVLA Form 4 filing on record
Up to 3 months of PVLA price history
The daily trading plan of ranked insider buys, on a delay, with the plan archive

Start 7-day demoCard required. Your card is never charged for the demo.

Form 4 transaction type

Transactions

Total value

Open-market sale

40,719

$6.17M

Option exercise

26,438

Date

Insider

Transaction

Security

Price

Value

Sep 16, 2026